Since 2020, Drug Topics has partnered with the healthcare business of LexisNexis Risk Solutions to take the pulse of the pharmacy profession. We invite you to take the 2023 survey, providing a look back at 2023 and a snapshot of what 2024 may hold for the pharmacy profession.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.